(HealthDay News) — The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.

The FDA approved Moderna’s lower-dose COVID-19 vaccine, but only for individuals aged 65 years or older and people aged 12 to 64 years at high risk for severe disease, aligning with the agency ...

The new vaccine, mNexspike, is a step toward next-generation coronavirus vaccines. It's made in a way that allows for a lower dose — a fifth of the dose of its current COVID-19 vaccine, Spikevax ...

The US Food and Drug Administration (FDA) on Saturday approved a new, lower-dose Moderna-made vaccine. However, this will not be a replacement for the company’s existing shot.

The Food and Drug Administration has approved a lower-dose COVID-19 vaccine. Ernst doubles down on Medicaid comment with sarcastic video ‘apology’ Valerie Mahaffey, Actress on ‘Northern ...

The U.S. approved a new COVID-19 vaccine made by Moderna but with limits on who can use it — not a replacement for the company’s existing shot, but a second option.

Business FDA approves Moderna’s new lower-dose COVID-19 vaccine FILE - The U.S. Food and Drug Administration campus in Silver Spring, Md., is photographed on Oct. 14, 2015.

Among 2,491,770 COVID-19-positive emergency or inpatient encounters analyzed, 1,307,321 (52.5%) included pain complaints and 1,184,449 (47.5%) did not.

Hemoperfusion treatment may decrease the risk of dying from COVID-19 in patients on maintenance dialysis, an investigator reported at the American Society of Nephrology’s (ASN) Kidney Week 2024 ...

The Glock 17 and Glock 19 are both boxy, plain black, nearly featureless pistols that changed the way we think about handguns. Just 34 parts were brought together by a guy who had never built a gun ...